Know Cancer

or
forgot password

Randomized Clinical Trial for Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye


N/A
18 Years
N/A
Not Enrolling
Both
Chalazion, Dry Eye Syndromes

Thank you

Trial Information

Randomized Clinical Trial for Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye


Inclusion Criteria:



- At least 18 years of age.

- Meibomian gland obstruction

- Dry eye symptoms

- Willingness to comply with study procedures and return for all visits

Exclusion Criteria:

- Ocular surgery, injury, or herpes infection within past 3 months

- Active ocular infection

- Active ocular inflammation or recurrent inflammation within past 3 months

- Moderate to severe allergic conjunctivitis

- Severe eyelid inflammation

- Eyelid abnormalities that affect lid function

- Ocular surface abnormalities that may compromise corneal integrity

- Macular disease

- Systemic disease condition or medication that causes dry eye

- Use of other treatments for meibomian gland dysfunction or dry eye

- Pregnant or nursing women

- Participation in another ophthalmic clinical trial within past 30 days

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Meibomian Gland Assessment (Total Meibomian Gland Secretion Score)

Outcome Description:

Evaluation of secretion characteristics from the gland orifices along the lower eyelid. Assessment was based on the grading scale: 3 (clear liquid secretion), 2 (cloudy liquid secretion), 1 (inspissated), 0 (no secretion). The total meibomian gland secretion score was the sum of the grades for all 15 glands with a range of 0 to 45.

Outcome Time Frame:

Baseline, 2 Weeks and 4 Weeks

Safety Issue:

No

Principal Investigator

Christy Stevens, OD

Investigator Role:

Study Director

Investigator Affiliation:

TearScience, Inc.

Authority:

United States: Institutional Review Board

Study ID:

LF001

NCT ID:

NCT00832130

Start Date:

February 2009

Completion Date:

August 2009

Related Keywords:

  • Chalazion
  • Dry Eye Syndromes
  • Chalazion
  • Dry Eye Syndromes
  • Keratoconjunctivitis Sicca

Name

Location

Hinsdale, Illinois  60521
Alexandria, Minnesota  56308
Albany, Georgia  31701
Philadelphia, Pennsylvania  19104
Flint, Michigan  48532
Louisville, Kentucky  40207
Little Rock, Arkansas  72205-7199
Boston, Massachusetts  
Charlotte, North Carolina